Right to Try laws allow Big Pharma to exploit patients' hope

“Right to Try laws allow Big Pharma to exploit patients’ hope,” Diana Zuckerman, Chicago Tribune.

If you were dying of a terminal illness and your doctor said there were no proven treatments, would you take the risk of trying an experimental, unproven drug? Many patients would say yes. But as with most medical decisions, the . . . → Read More: Right to Try laws allow Big Pharma to exploit patients’ hope

Trumping the Affordable Care Act

“On day one of the Trump Administration, we will ask Congress to immediately deliver a full repeal of Obamacare.

However, it is not enough to simply repeal this terrible legislation. We will work with Congress to make sure we have a series of reforms ready for implementation that follow free market . . . → Read More: Trumping the Affordable Care Act

Book Review: Hospital Land USA

Death is certain. Time of death is not. But in Hospital Land USA, the other S&M (Science and Medicine) as Wendy Simonds calls it, death is a failure, something to be suspended and avoided at whatever cost. And there is no safe word. The surreal ordinariness of it all – from appointments and forms to . . . → Read More: Book Review: Hospital Land USA

Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice

PAGES: 1 2 3

Is Childlessness Really Another Side Effect of Cancer?

The emphasis on biological motherhood in the field of oncofertility masks at least two societal forces contributing to the cancer/infertility equation.

First, the conditions in which people live and work are are already linked to cancers and adverse effects on women’s . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice – 3

Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice

PAGES: 1 2 3

Rethinking Normative Expectations

As professionals, we have to balance our responsibility to care, inform and research for safer fertility treatments while respecting women’s choices that may at times go against dominant models of womanhood. In doing so, it is crucial to acknowledge several problems stemming from norms about reproduction . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice – 2

Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice

PAGES: 1 2 3

Cancer and cancer treatments can have a huge impact on women’s sexual and reproductive health. Yet, when I started my research on breast cancer and social inequality in Spain a decade ago this issue was hardly being addressed in international scholarly debates or in clinical settings. Several of the . . . → Read More: Oncofertility: Beyond Biological Motherhood, Towards Reproductive Justice

Sheryl Crow hawks 3D mammograms with fear and false hope

“Sheryl Crow hawks 3D mammograms with fear and false hope”, Health News Review.

It may not be her favorite mistake, but it was a mistake nonetheless for the singer and breast cancer survivor Sheryl Crow to advocate in an aggressive, unbalanced way on behalf of a 3D mammography device.

That’s the takeaway of a number . . . → Read More: Sheryl Crow Hawks 3D Mammograms with Fear and False Hope

Breast cancer-detecting bra won’t go away–and the news coverage is still sub-par

By Kathlyn Stone

This post appeared originally on Health News Review (HNR). HNR evaluates health care journalism, advertising, marketing, public relations and other messages that may influence consumers and provides criteria that consumers can use to evaluate these messages themselves. Improving the quality and flow of health care news and information to consumers can be . . . → Read More: Breast cancer-detecting bra won’t go away–and the news coverage is still sub-par

Drug Prices Soar, Prompting Calls for Justification

“Drug Prices Soar, Prompting Calls for Justification,” by Andrew Pollack, The New York Times.

Prices for cancer drugs, some of which extend lives by only a couple of months, routinely exceed $100,000 a year, and some new ones exceed $150,000. And it is not unusual for the list prices of existing drugs to rise 10 . . . → Read More: Drug Prices Soar, Prompting Calls for Justification

How Not to Fix the F.D.A.

“How Not to Fix the F.D.A.,” by The Editorial Board, The New York Times.

A bill passed by the House and ostensibly designed to streamline the Food and Drug Administration is loaded with bad provisions and may not even be necessary. The Senate should either eliminate or rewrite the flawed . . . → Read More: How Not to Fix the F.D.A.

Articles & Posts